Asthma Summit 2011
Athens, Greece
10 – 11 November 2011
Rules for Abstract Submission
Abstract submission will open 1 September 2011 and close on midnight, 30
September 2011. Only one abstract per applicant can be submitted.
Word Count: 300 words maximum (Text, not including authors and affiliations)
Abstracts must be written in the following format:
Font Style Verdana, 10, single spaced.
Title Verdana, 10, bold, single spaced. Do not capitalize title.
Space
● Authors Verdana, 10, single spaced. First name and family name; underline presenting
author.
Space
● Affiliations Verdana, 10. Name of Institute or University, town, country, e-mail of
presenting author.
Space
● Abstract’s Text Body Verdana, 10, single spaced.
●
Do Not
Do not use “symbol font”. Please spell out Greek Letters and avoid using other symbols.
Do not include tables, figures, or references.
● Do not use paragraphs, indentions or tab stops in the text body of the abstract.
●
●
Example
A role for T cell independent interleukin-10 in allergen specific
immunotherapy
Stefanie Kunz1, Mayte Bewersdorff2, Sangeetha Surianarayanan3, Francesca
Alessandrini2, Heidrun Behrendt2, Martin Mempel2, Axel Roers3, and Thilo Jakob1
1 Allergy Research Group, University Medical Center, University of Freiburg, GER
2 ZAUM Center for Allergy and Environment GSF/ Technische Universität, Munich, GER
3 Institute of Immunology, Univiversity of Dresden, GER
E-mail: [email protected]
Human studies have suggested that allergen immunotherapy leads to the induction of
regulatory immune responses that actively suppress the development of allergic
inflammation. IL-10 production by allergen-specific T cells has been suggested as one
of the main regulatory mechanisms. This was supported indirectly by in vivo
observations in mice treated with IL-10 neutralizing mAb, in which the beneficial
effects of immunotherapy were largely abrogated. However IL-10 is secreted by a
variety of different cell types and the formal proof that T cell derived IL-10 is required
for successful immunotherapy is still lacking. In the present study we address....
Abstract Submission
Asthma Summit 2011
Athens, Greece
10 – 11 November 2011
Abstract Submission
Presenting Author
Family Name
First Name
Degree
Institute/University
Address
Phone
E-Mail
Please answer the following questions:
● Are you an EAACI Member (full member or JMA)?
● Are you a JMA member of the Asthma Section?
Yes/No
Yes/No
Send the Abstract Form as an e-mail attachment to: [email protected]
n.b. Abstract Submission opens on 1 September and closes on midnight, 30 September 2011.
Abstract (Please write below your abstract strictly adhere to the rules of the abstract
submission)